Arkolith/Insider Trading/SLRX/Form 4

Hanish Arnold C

DirectorSalarius Pharmaceuticals, Inc. (SLRX) · full profile →Form 4 · filed Jan 2, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$17
Net Open-Market Flow
-$17
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 30, 2025Sell(S)15$0.64$105K
Dec 30, 2025Sell(S)12$0.64$80

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001615219-26-000004) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML